Category:

Accelerating the Development of Evidence Reviews and Recommendations in Genomic Medicine

The independent EGAPP working group (EWG) held its 26th meeting on February 11-12, 2013 at the CDC campus in Atlanta. Highlights included: Three EWG recommendation statements on the validity and utility of genetic tests are pending publication on: KRAS, BRAF and other markers involved in EGFR signaling, which are used to inform choice of therapies for Read More >

February 28, 2013 by Michael P. Douglas and W. David Dotson, Office of Public Health Genomics, Centers for Disease Control and Prevention

evidence-based medicine, genomics

genetic testing, genetics, genomics, public health

How Can We Use Genetic Testing in Population Screening for Common Diseases?

Scientific and implementation challenges Population screening for disease is a concept that has been around for many decades. Its main purpose is early detection and treatment of asymptomatic disease, or risk assessment and prevention of future disease, in order to improve health outcomes in individuals and populations. Examples include mammography in breast cancer screening and Read More >

February 21, 2013 by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and Prevention1 Comment

genomics, Population screening

disease, genetic testing, public health